Summary Loss of GLUT 2, the glucose transporter isoform of pancreatic beta cells, has been reported to accompany the onset and perhaps contribute to the pathogenesis, of insulin-dependent and non-insulindependent diabetes mellitus in BB/Wor and Zucker fatty rats. In this study we investigated the effect of Kilham Rat Virus infection on GLUT 2 expression in diabetes-resistant BB/Wor rats. Viral antibodyfree diabetes-resistant rats do not develop spontaneous diabetes, but inoculation with Kilham Rat Virus induces autoimmune beta-cell destruction and hyperglycaemia. Pancreas sections from normoglycaemic diabetes-resistant BB/Wor rats were obtained 5, 7 and 25 days after inoculation with Kilham Rat Virus and stained for GLUT 2 using a rabbit polyclonal antibody. At all time points, beta cells displayed GLUT 2 expression comparable to uninfected diabetes-resistant controls. Immunostained insulin content of the beta cells also remained unchanged. Sections were also examined from Kilham Rat Virus inoculated diabetes-resistant rats with lymphocytic insulitis or diabetes. GLUT 2 and insulin immunostaining were unchanged in non-diabetic rats with early insulitis. GLUT 2 beta-cell staining was variably reduced in diabetic rats with established insulitis and reduced beta-cell insulin immunostaining. Hence, the initial stages of Kilham Rat Virus-induced diabetes in diabetes-resistant rats are not accompanied by a significant reduction in GLUT 2 expression. These results suggest that the loss of GLUT 2 does not play a significant role in the aetiology of diabetes in the Kilham Rat Virus-infected diabetes-resistant BB/Wor rat. [Diabetologia (1994) animal models of insulin dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM) [4] [5] [6] [7] . The Zucker diabetic fatty (ZDF) rat displays obesity and insulin resistance. Only male rats develop diabetes with an associated loss of insulin response to glucose [4] . Obese male diabetic ZDF rats revealed decreased beta-cell GLUT 2 protein and mRNA at the onset of diabetes, compared to obese non-diabetic female and lean non-diabetic male Zucker rats [4, 6] . Glucose-induced insulin release in obese diabetic ZDF rats was correlated with the level of beta-cell GLUT 2; glucose-induced insulin release by the isolated perfused pancreas was absent in rats with fewer than 60 % GLUT 2 positive beta cells. In contrast, arginine infusions elicited a strong insulin secretory response,
animal models of insulin dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM) [4] [5] [6] [7] . The Zucker diabetic fatty (ZDF) rat displays obesity and insulin resistance. Only male rats develop diabetes with an associated loss of insulin response to glucose [4] . Obese male diabetic ZDF rats revealed decreased beta-cell GLUT 2 protein and mRNA at the onset of diabetes, compared to obese non-diabetic female and lean non-diabetic male Zucker rats [4, 6] . Glucose-induced insulin release in obese diabetic ZDF rats was correlated with the level of beta-cell GLUT 2; glucose-induced insulin release by the isolated perfused pancreas was absent in rats with fewer than 60 % GLUT 2 positive beta cells. In contrast, arginine infusions elicited a strong insulin secretory response, even in diabetic animals with very low beta-cell GLUT 2 levels [4] .
The BB/Wor rat develops spontaneous autoimmune insulitis, leading to beta-cell destruction in a manner resembling IDDM in humans. Orci et al. [8] reported that decreased numbers of GLUT 2 positive beta cells were present on the first day of overt diabetes. Furthermore, although there was no detectable insulin response to glucose in the isolated perfused pancreas of acutely diabetic BB rats, arginine infusions still elicited a brisk and significant insulin response [8] . Therefore, the loss of GLUT 2 from the remaining beta cells appeared to augment the loss of beta cell function due to autoimmune destruction.
Neither in vivo nor in vitro elevated glucose levels have been reported to reduce beta-cell surface GLUT 2 immunostaining in islets of non-diabetic lean rats [6] . Immunodetectable beta cell GLUT 2 was not reduced in lean Wistar rats with chronic hyperglycaemia (7 days) induced by i.v. infusions of a 50 % glucose solution [6] . Conversely, the reduction of glycaemic levels in acarbose-fed obese male diabetic ZDF rats did not restore beta cell GLUT 2 levels to those of non-diabetic obese female rats or lean animals [6] . Therefore, the reduction in betacell GLUT 2 observed in the lean BB and obese ZDF animal models was interpreted to be a manifestation of an intrinsic defect in the beta cell rather than the consequence of hyperglycaemia.
The BBDR/Wor (diabetes-resistant) rat was de= rived from parental diabetes-prone (DP) progenitors at the University of Massachusetts, Worcester colony. Unlike DP rats, which show decreased numbers of circulating and tissue T lymphocytes (lymphopenia), DR rats are non-lymphopenic and do not develop insulitis or diabetes if raised in a viral antibodyfree (VAF) environment [9] . However, lymphocytic insulitis, beta cell destruction and diabetes are induced in DR animals infected with the parvovirus Kilham Rat Virus (KRV) [10] . DR rats housed in conventional (i. e. virus-containing) surroundings display a low incidence of spontaneous diabetes, which is greatly increased by treatments which perturb the immune system, e.g., polyinosinic-polycytidylic acid (poly I : C) injections [11, 12] , depletion of RT6.1 + T-cells [13] , X-irradiation [14] and cyclophosphamide [15] .
The purpose of the present study was to evaluate the effects of KRV infection, and KRV-induced insulitis and diabetes on beta-cell GLUT 2 immunostaining in BBDR/Wor rats. We wanted to examine whether loss of GLUT 2 occurred in KRV-induced diabetes and whether it preceded or was concomitant with autoimmune beta-cell destruction. We thus wished to ascertain whether altered beta-cell GLUT 2 played a role in the KRV model of autoimmune diabetes.
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Materials and methods
Animals. BBDR/Wor rats were produced in the NIH-supported research and contract colonies located at the University of Massachusetts Medical Center. DR rats have been inbred for more than 50 generations, and have been completely free of spontaneous insulitis and diabetes since the colony was Caesarian-derived into a Viral antibody-free facility in 1989. Rats were fed autoclaved chow (Purina 5010; Purina, St.Louis, Mo., USA) and given drinking water ad libitum.
To evaluate the effects of KRV infection on pancreatic islet morphology and immuno-histochemistry, we studied KRV-infected rats derived from two study groups. In study 1, the "Time course study", pancreatic tissues were obtained from non-diabetic DR rats that were killed at early intervals after KRV infection, prior to the expected onset of hyperglycaemia. In study2, the "GLUT2 expression during insulitis study", pancreata were analysed from animals with documented KRV-induced lymphocytic insulitis or diabetes.
Time course study. Twelve DR rats comprising both sexes, 27-31 days of age, were injected i.p. with 0.1 ml of a i : 6 dilution (approximately 5 x 107 plaque-forming units) of the University of Massachusetts KRV isolate [10] . Six of the 12 rats also received injections of anti-RT6.1 monoclonal antibody (DS4.23 from Dr. D.Greiner, University of Massachusetts Medical Center), 1.5 ml i.p. daily for 1-4 days before KRV injection. RT6 is an alloantigen found on 45 % and 80 % of peripheral CD4 and CD8 cells, respectively [16] . Two allelic forms exist, RT6.1 and RT6. 2 [17] . The BBDR/Wor rat expresses the RT6.1 form [13] . Depletion of RT6.1 + T cells increases the frequency of diabetes in KRV-infected DR rats (Like, unpublished data). Animals were killed 5 days (3 rats, 1 DS4.23 treated), 7 days (4 rats, 3 DS4.23 treated) and 25 days (5 rats, 2 DS4.23 treated) after KRV injection.
GLUT2 expression during insulitis study. Eighteen DR rats comprising both sexes, 18-57 days of age, were injected with 0.1-0.2 ml of a 1 : 6 dilution (approximately 5 x 107 plaqueforming units) of either the University of Massachusetts KRV isolate or the National Cancer Institute KRV isolate (T953000, provided by W.Shek, Charles River Laboratory, Wilmington, Mass., USA), and killed at 34-85 days of age. One of the 18 rats also received injections of anti-RT6.1 monoclonal antibody, 2 ml i.p. daily for 1-4 days before KRV injection. Ten rats were diabetic when killed.
Diabetes testing. Animals were tested for glycosuria three times a week using TesTape. Tail blood was obtained from glycosuric animals for glucose measurements using a glucose analyzer (Beckman Glucose Analyzer 2, Irvine, Calif., USA). Diabetes was defined as 4 + glycosuria and blood glucose greater than 13.9 mmol/1.
Tissue processing and immunohistochemistry. Pancreatic tissues were fixed in Bouin's solution and embedded in paraffin. For GLUT 2, we used an adaptation of the immunostaining method of Orci et al. [8] . Deparaffinized sections (4 ~m) were incubated with rabbit anti-GLUT 2 polyclonal antibody (#1092 from C.B. Newgard and J.H. Johnson, University of Texas, Dallas, Tex., USA) at 1:500 dilution in buffer (0.01 tool/1 sodium phosphate, 0.9 % sodium chloride, 0.1% sodium azide, 0.1% bovine serum albumin (BSA) RIA grade, pH 7.4) overnight at 4 ~ in a saturated water vapour atmosphere. The sections were washed three times in 0.01 tool/1 sodium phosphate, 0.9 % sodium chloride buffer, pH 7.4, followed by a I h incubation at room temperature with peroxidase conjugated porcine anti-rabbit antibody (Dakopatts, Glostrup, Denmark) 1 : 100 dilution in 0.01 tool/1 sodium phosphate, 0.9 % sodium chloride, pH 7.4. The sections were washed as before. Reaction product was revealed by a 90-s incubation in 0.01 mol/1 sodium phosphate, 0.9 % sodium chloride buffer pH 7.4 containing 0.025 % 3,3'-diaminobenzidine (Sigma, St. Louis, Mo., USA) + 0.015 % H202. For insulin and glucagon immunostaining, sections were incubated overnight at 4 ~ with either guinea-pig anti-porcine insulin (Dako, Carpinteria, Calif., USA), or rabbit anti-glucagon antibody (from Dr. M.Appel, University of Massachusetts Medical Center) at dilutions of 1 : 150 and 1 : 2500, respectively, in 0.05 mol/1 Tris, 0.9 % sodium chloride, 1% normal horse serum (NHS), pH 7.6. Sections were washed for 10 min in the same buffer and incubated for 1 h at room temperature with swine anti-rabbit antibody (Dako, Glostrup, Denmark) 1 : 200 dilution in 0.05 mol/1 Tris, 0.9 % sodium chloride, 1% NHS, pH 7.6. Sections were washed as before and incubated for i h with rabbit peroxidase anti-peroxidase conjugate (Dako, Glostrup, Denmark), 1 : 500 dilution in 0.05 tool/ 1 Tris, 0.9 % sodium chloride, 1% NHS, pH 7.6. Following a 10-min wash in 0.05 mol/1 Tris, staining was revealed with a 4-7 rain incubation in 0.02 % diaminobenzidine in 0.05 mol/1 Tris, 0.9 % sodium chloride, 0.01% H20 2. All sections were counterstained with haematoxylin, dehydrated and mounted using Permount mounting medium (Fisher, Fair Lawn, N.J., USA).
Consecutive, or near-consecutive sections were immunostained for GLUT 2, insulin and glucagon. By examining all islets visible in the plane of the section, the degree of insulitis was estimated (none, mild, moderate, severe), as was the estimated percentage of remaining beta cells (visualised by insulin staining) staining visibly positive for GLUT 2. The amount of GLUT 2 expression was scored on an arbitrary scale of 1+ to 4+ as follows: 0-25%=1+; 25-50%=2+; 50-75% = 3 + ;75-100% =4 +.
Results
Study 1.
Of the twelve rats studied, none developed diabetes during the course of the experiment. After the animals were killed, subsequent immunohistochemical examination revealed mild insulitis in two of the rats (not treated with anti-RT6.1 monoclonal antibody) killed 25 days after KRV infection. All 12 rats showed GLUT 2 expression of 4 +. Figures 1-4 show pancreatic sections from a normal uninfected DR rat (Fig. 1) , and from selected examples of DR rats killed at 5 (Fig. 2), 7 (Fig. 3) and 25 ( Fig. 4) days following KRV-infection, after staining for (a) GLUT 2, (b) insulin and (c) glucagon. GLUT 2 staining in normal rat islets (Fig. i a) is localized to the cell membranes of centrally located betacells (defined by positive staining for insulin, Fig. i b) , and is not present in the glucagon-positive peripheral alpha-cell area of the islet (Fig. i c) . At 5 (Fig. 2) and 7 ( Fig. 3) days after KRV injection, insulitis is not evident, beta cells appear normal, and GLUT 2, insulin and glucagon staining are unchanged. At 25 days post-infection (Fig. 4) , mild lymphocytic peri-insulitis is present. The cytoarchitecture of the islets is, however, preserved and there is no diminution in beta-1189 cell GLUT 2 staining (Fig. 4 a) . Insulin (Fig. 4b) and glucagon (Fig.4c) staining are also unchanged. There was no difference in islet morphology or immunohistochemistry between unpretreated DR rats and DR rats pretreated with anti-RT6.1 monoclonal antibody (results not shown). Figures 5-8 illustrate consecutive or nearconsecutive sections of four different islets which depict mild (Fig. 5) moderate (Fig. 6 ) and severe (two stages, Figs.7 and 8 ) lymphocytic insulitis. GLUT 2 staining is fully preserved in the surviving beta cells of the islet with mild insulitis (Fig. 5 a) . With moderate insulitis, there is focal reduction in GLUT 2 staining (Fig. 6 a) , particularly in beta cells adjacent to loci of lymphocyte infiltration. The reduction in GLUT 2 is more evident in Figure 7 a. Total loss of GLUT 2 expression, however, is not noted until the number of surviving beta cells has been substantially reduced (Fig. 8 a) . Note that the surviving GLUT 2 negative beta cells still reveal insulin immunostaining (Fig. 8b) . The intensity of glucagon staining is unchanged with the increasing degree of insulitis (Figs.5c-8c) , although the islet cytoarchitecture is disrupted. Table 1 shows the combined results of Studies 1 and 2 and reveals the relationship between the degree of lymphocytic insulitis (none, mild, moderate, severe) and the estimated percentage of surviving beta cells expressing cell-surface GLUT 2. None of the 14 rats without insulitis displayed any reduction in immunostainable beta-cell GLUT 2. In the six rats with mild insulitis, there was also no reduction in GLUT 2 immunostaining. Of the five rats with moderate insulitis, three revealed varying degrees of reduced GLUT 2 staining, and two revealed GLUT 2 on all or nearly all surviving beta cells. GLUT 2 staining was reduced in all five animals with severe insulitis. There were no apparent differences in the pattern of GLUT 2 expression in the rats treated with KRV alone and those which received anti-RT6.1 (DS4.23) antibody prior to KRV (data not shown). GLUT 2 immunostaining is secondary to insulitis rather than a primary event that occurs early in the development of this disease; (2) hyperglycaemia in KRV-infected DR rats is due to beta-cell destruction, rather than the result of the loss of GLUT 2 from otherwise intact beta cells; (3) hyperglycaemia per se is not responsible for loss of beta cell GLUT 2; (4) although virus levels in blood and tissues (including the pancreas) are highest at 5 and 7 days post-KRV inoculation [10] , the presence of normal GLUT2 and insulin immunostaining at these early times argues against the possibility that direct infection of beta cells by KRV is responsible for a loss of GLUT 2 mediated glucose transporter function. In addition, the beta cells appear to be morphologically normal and functionally unaffected (animals are normoglycaemic) during the early stages of KRV infection. Histologic evidence of beta-cell loss and reduced GLUT 2 staining was evident only in islets with lymphocytic insulitis. These findings therefore support the hypothesis that the autoimmune process which follows KRV infection of DR rats is the result of a perturbation of the immune system rather than the result of direct virus-induced beta cell injury. Tal et al. [18] reported the absence of a correlation between expression of GLUT 2 on beta-cells and glucose uptake and utilization rates. In addition, the rate of glucose transport across the beta-cell membrane was found to be far in excess (about 100-fold) of the rate of glucose utilization. Ohneda et al. [19] reported that glucose-stimulated insulin secretion in 12-week-old diabetic Goto-Kakizaki (GK) rats was reduced by 80 % compared with age-matched control rats, although the number of GLUT 2 positive betacells was reduced by only 10 %. A similar discrepancy between the reduction in beta-cell GLUT 2 and loss of glucose-stimulated insulin release has been reported for dexamethasone-induced diabetes in Zucker fatty rats [20] . Chen et al. [21] reported that the restoration of glucose-induced insulin secretion in neonatal streptozotocin diabetic rats induced by perfusion of the pancreas with a glucose-deficient medium occurs without an increase in beta-cell GLUT 2 immunostaining. These results suggest that the loss of GLUT 2 Cannot be the sole cause of betacell dysfunction in these models of diabetesl However, if the loss of GLUT 2 is of a sufficient magnitude, then glucose transport may, in fact, become rate-limiting. The enhanced glucose-induced insulin release elicited by glucopenia in neonatal streptozotocin rats was abnormal in that there was a leftward shift of the dose-response curve, with a blunted second phase [21] . Hence, under certain conditions, GLUT 2 on the plasma membrane of beta cells may in fact contribute to normal glucose responsiveness. Another report [22] suggests that the relationship between GLUT2 and glucose-induced insulin secretion involves factors other than glucose transport. In-1193 sulin-secreting AtT-20in s cells transfected with cDNA for GLUT 2 or GLUT 1 show similar glucose utilization rates. However, only the cells transfected with GLUT 2 cDNA display glucose sensitivity. Therefore, although both transporter isotypes confer similar glucose transport abilities on AtT-20in s cells, only the GLUT 2 isotype can provide glucose-stimulated insulin release.
Study 2.
As viral proteins and gene products have not been identified in the BBDR/Wor beta cells following KRV infection [10, 23] , it is unlikely that autoimmune destruction is directly elicited by viral antigens or gene products in or on the beta cell. A proposed mechanism for KRV-induced diabetes in the DR rat is that the virus induces a "disturbance" in the immune system which leads to immune destruction of pancreatic beta cells. That the DR rat possesses a genetic predisposition to develop diabetes is suggested by reports that diabetes can be induced in conventionally housed (i. e. viruses present) DR rats by a variety of experimental procedures that perturb the immune system. Therefore, we predict that the same beta-cell target antigen(s) are the target of the autoimmune attack in both the spontaneous diabetes of the BBDP/ Wor rat and KRV-induced diabetes in the BBDR/ Wor rat. GLUT 2 has been suggested as a putative beta-cell autoantigen [24, 25] . The results of this study neither support nor contradict this possibility. Since GLUT 2 does not disappear from the beta-cell membrane early in the course of KRV-induced diabetes, the persistence of this protein may conceivably serve as a target for the autoreactive effector ceils.
